Withdrawal Of Tavneos (avacopan)

TAVNEOS (avacopan), a prescription medicine, is being withdrawn from the Australian market because the company that distributes it in Australia has decided to stop supplying it. This withdrawal applies to all TAVNEOS products currently available in Australia.

Reason

The Australian sponsor for the prescription medicine TAVNEOS (avacopan) has advised us of their intent to withdraw it from the Australian Register of Therapeutic Goods.

Classification

Class III

Category

drug recall

Country

Australia

Agency

Therapeutic Goods Administration

Recall date

2026-10-16

Status

Ongoing

Distribution

Australia-wide

Official recall notice from Therapeutic Goods Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/49260e3d-d2cd-48dc-a188-323909c70c16